Leverage Shares 1x ARK Genomic Tracker ETP - USD Stock

ETF

ARKC

XS2399368062

Real-time Euronext Amsterdam 09:38:05 2025-02-10 am EST
2.100 EUR -0.84% Intraday chart for Leverage Shares 1x ARK Genomic Tracker ETP - USD
Current month-0.84%
1 month+5.14%
Dynamic Chart

Investment objective

The objective of the LS ARKG Genomic Tracker ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the Reference Asset), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
Add to a list
Price
Change
5d. change
1st Jan change
31.39USD-0.03%-2.18%-10.10%6.89%
52.36USD-2.19%-5.15%-6.75%6.8%
39.44USD-0.69%-1.55%+0.05%4.53%
13.96USD+7.80%+39.00%+53.69%4.28%
9.705USD-0.87%+1.94%-16.60%4.17%
22.38USD-0.13%-4.55%+3.97%4.15%
26.40USD-3.67%+3.40%+6.69%4.1%
25.44USD-0.92%+2.59%+31.47%3.98%
1.245USD-1.97%-1.04%-23.83%3.95%
See all (47)
In partnership with
TrackInsight
Date Price Change
25-02-10 2.100 -0.84%
25-02-07 2.157 -3.68%
25-02-06 2.240 +4.37%
25-02-05 2.146 +1.43%
25-02-04 2.116 +0.96%

Real-time Euronext Amsterdam

Last update February 10, 2025 at 09:38 am EST

More quotes

Description

XS2399368062
Total Expense Ratio 0.35%
Asset Class Equities
Sector
Size
Currency
Provider

Features and characteristics

Dividend Policy Capitalisation
Jurisdiction
Fund Structure
Date of creation
2021-12-13
Geographical Focus

Distribution

Retail investor

AuM evolution ( 2024-12-30 )

AuM (EUR) 1 M€
AuM 1M 1 M€
AuM 3 months 1 M€
AuM 6 months 1 M€
AuM 12 months 0 M€
  1. Stock Market
  2. ETF
  3. ARKC ETF